A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Trial details
- Registry ID
- NCT07749586
- Phase
- Phase 1, Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid TumorsNCT07749586 | ARVN | Phase 1, Phase 2 | Recruiting | 2031-03-31Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |